Double the Volume and Glass-Free Packaging among Key New Features

Erlanger, KY –Union Springs Pharmaceuticals, LLC, today announced some key upgrades to its MyClyns® Professional units that provide additional value to its users.  In times when manufacturers are raising prices and cutting volume, MyClyns new packaging now contains double the volume of solution (12 ml) for the same price as the previous MyClyns professional spray (6 ml).  Additionally, in response to feedback by its customers, the spray mechanism no longer contains an interior glass vial.

MyClyns is the groundbreaking germ defense spray that has been trusted by public safety, police, military, health care and EMS officials in the United States, Canada, and Europe and has been endorsed by the National Sheriffs’ Association and many other organizations. The overwhelming success of MyClyns has resulted in sales more than doubling this past year.

The solution in MyClyns reduces more than 60 clinically important pathogens by 99.99 percent and is the only product that can be safely sprayed in the eyes, mouth, nose, and in minor cuts and abrasions, where germs are most likely to enter the body.  MyClyns is a pen-sized device, which allows first responders to protect themselves immediately after exposure to bodily fluids.

“MyClyns personal germ protection spray was designed with the public safety official in mind and situations when their safety is our top priority,” Union Springs Pharmaceuticals president Joel Ivers said. “With MyClyns now containing twice the volume of solution, we are providing our customers twice the germ protection when they are exposed to harmful pathogens. Because of our new design, we have been able to provide this significant advantage without raising our price.  Additionally, the glass-free packaging provides added peace of mind and is invaluable to correction and police officers while tending to even the most precarious situations.”

MyClyns has been purchased by over 2,000 municipalities in the U.S. and in 35 countries worldwide. The product is available in black or white.  Visit www.clynsbrands.com or call 1-877-Go-Clyns to find a distributor or to order directly from the company.

###

About Union Springs Pharmaceuticals, LLC

Union Springs Pharmaceuticals specializes in providing innovative personal and environmental protection products for the EMS, fire, law enforcement, corrections, military, government, healthcare and consumer markets. Union Springs Pharmaceuticals currently markets MyClyns, the revolutionary personal protection spray that can be applied into the eyes, nose and mouth.  It has just launched its newest product, ViralClyns™, the only flat-fold respirator with the comfort and breathability of a face mask plus an infused EPA-approved antimicrobial.  The company also offers the T-5000 and T-5000V P-95 respirators, the only P95 disposable respirators with antimicrobial technology. More information on Union Springs Pharmaceuticals and its products can be found at www.ClynsBrands.com.

Editor’s Note:

High Resolution Photo Available

Samples Available for Review

Whether you work, travel or have children, it seems as though you’re constantly at risk for catching the latest bug going around. No matter how many precautions you take, those devious germs still find a way to make you sick.

That’s because germs don’t enter the body through our skin, but through susceptible areas like our eyes, nose, mouth, and abrasions. When we touch our eyes or mouth with unclean hands or objects, germs are given an express lane entrance.  When we’re in close proximity with others, such as at work, school or during simple interactions, we’re at risk.

But one Kentucky-based company has release a new product that has germaphobes rejoicing. Previously available only to professionals and a staple among police, fire fighters, corrections and healthcare workers, MyClyns® is the latest tool in the germ-defense arsenal. As a non-alcohol solution, MyClyns can be sprayed right into the eyes, nose, and mouth – even minor cuts and abrasions – without any stinging or burning.

How does MyClyns work? Let’s say you’ve just been coughed upon or have a sniffling, sneezing coworker sitting next to you. Simply take out your pen-sized MyClyns device, which contains about 50 sprays, and spray right into your mouth, eyes or any other entry point. Independent laboratory tests show that the solution in MyClyns reduces more than 60 pathogens by 99.99%.

It’s no wonder, then, that MyClyns is quickly becoming the new “must have” for savvy business travelers, office managers, and of course, mothers.

MyClyns was developed by Union Springs Pharmaceuticals to give first responders, military, and other health professionals another line of protection in the field, where they are often exposed to germs via third party blood and other bodily fluids. It is now available to consumers for the very first time.

The product, which retails for $9.99, can be purchased over the counter at most drug stores, supermarkets, and other general merchandise stores. Information about the product and its availability can be found at www.mygermspray.com.

So, germaphobes delight. You can leave less to chance this winter.

Union, Kentucky – August 19, 2009 – The makers of MyClyns®, Union Springs Pharmaceuticals, has received an additional round of Series A Financing by several investors including Cincinnati-based Blue Chip Venture Company.  The round totaled in excess of $5 million. Union Springs Pharmaceuticals developed the Clyns Brand germ defense products initially designed for first responders. According to chairman and founder Roger Griggs, the infusion of cash will enable the company to ramp up the sales and marketing organization to take advantage of the tremendous interest in the company’s products and expand its reach into the healthcare and consumer market segments.

The Clyns Brands products that are marketed by Union Springs Pharmaceuticals gained mainstream popularity after recent H1N1 swine flu breakouts.  Both the T-5000 respirator and the MyClyns personal protection spray have already proven to be significant assets to public safety officials, military, corrections, and EMS personnel throughout the United States. Expansion into Canadian and European first responder and consumer markets poises the Northern Kentucky-based company for rapid growth.

“We have been fortunate to raise capital from multiple funding sources over the years, and it is particularly rewarding to have several local investors join Blue Chip, as well as several investors from outside of the region, to form our cornerstone of participants” Griggs said.

The Clyns Brands product line includes the only germ-fighting spray for the eyes, mouth, nose, and open wounds.  Independent laboratory tests have shown a 99% reduction of more than 60 pathogens, including MRSA, within 30 seconds after use. Union Springs Pharmaceuticals also markets a line of P95 disposable respirators with Triosyn^® antimicrobial technology that are effective against numerous pathogens including the flu virus, bacteria, spores, fungi and protozoa.

Blue Chip Managing Director Jack Wyant explained that his organization partners with companies that have strong, experienced executive teams that are “highly ethical, passionate and strategic, and have a proven track record of success. We have found this to be so in our past successes with Roger Griggs and are highly optimistic about the prospects for the future of this organization, its products and its people.”

About Union Springs Pharmaceuticals

Union Springs Pharmaceuticals, LLC specializes in providing innovative infection control products for the EMS, fire, law enforcement, corrections, military, government, healthcare, and consumer markets.  Union Springs Pharmaceuticals offers personal and environmental exposure response products including, MyClyns, the revolutionary germ-fighting spray that can be applied into the eyes, mouth, nose, and open wounds.  Union Springs also offers the T-5000 series disposable respirators, the only disposable respirator coated with a broad spectrum, EPA-registered antimicrobial (Triosyn^®) to help protect against small airborne threats.  The company has plans to launch several complimentary new technologies into the marketplace by the end of 2009. More information can be accessed at www.ClynsBrands.com or by calling 859.384.4029.

About Blue Chip Venture Company

Blue Chip Venture Company is a Cincinnati-based venture capital firm with $600 million under management, investments in over 100 companies, and offices in Indianapolis and New York.  Blue Chip invests in privately-owned, early stage, high growth companies in the healthcare, media and marketing and software industries.  More information about Blue Chip Venture Company can be found at www.bcvc.com.